Additionally, the combination has been shown to increase apoptotic cell death in HepG2.2.15 cells through alterations in the mTOR pathway, suggesting a promising approach for improving HCC treatment outcomes.30 This evidence concerns the gene MTOR and hepatocellular carcinoma.